Susan Ingle

519 total citations
9 papers, 329 citations indexed

About

Susan Ingle is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Cancer Research. According to data from OpenAlex, Susan Ingle has authored 9 papers receiving a total of 329 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pulmonary and Respiratory Medicine, 3 papers in Genetics and 3 papers in Cancer Research. Recurrent topics in Susan Ingle's work include Cancer, Lipids, and Metabolism (2 papers), Prostate Cancer Treatment and Research (2 papers) and Ethics in Clinical Research (1 paper). Susan Ingle is often cited by papers focused on Cancer, Lipids, and Metabolism (2 papers), Prostate Cancer Treatment and Research (2 papers) and Ethics in Clinical Research (1 paper). Susan Ingle collaborates with scholars based in United Kingdom, Cyprus and Sweden. Susan Ingle's co-authors include Carlos Caldas, Helena Earl, Paul D.P. Pharoah, Jean Abraham, Craig Luccarini, Alison M. Dunning, Mel Maranian, Roslin Russell, Inmaculada Spiteri and Leila Dorling and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Susan Ingle

8 papers receiving 319 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susan Ingle United Kingdom 6 124 89 83 77 38 9 329
Eef Hoeben Belgium 14 40 0.3× 65 0.7× 138 1.7× 21 0.3× 18 0.5× 22 394
Mengdan Yan China 12 51 0.4× 40 0.4× 154 1.9× 18 0.2× 55 1.4× 43 346
Joseph Maranville United States 11 33 0.3× 97 1.1× 166 2.0× 22 0.3× 30 0.8× 20 412
Yu Zhai China 13 42 0.3× 40 0.4× 101 1.2× 13 0.2× 70 1.8× 28 424
K. Walter Germany 11 61 0.5× 139 1.6× 127 1.5× 7 0.1× 27 0.7× 25 359
Tsuguru Hayashi Japan 12 52 0.4× 21 0.2× 52 0.6× 7 0.1× 13 0.3× 29 387
Louisa Dunk United Kingdom 5 48 0.4× 98 1.1× 23 0.3× 12 0.2× 15 0.4× 6 360
Radhika Narla United States 10 39 0.3× 87 1.0× 115 1.4× 6 0.1× 64 1.7× 19 353
Jeffery S. Babischkin United States 16 44 0.4× 123 1.4× 202 2.4× 13 0.2× 13 0.3× 33 610
Anupriya Kaur India 10 25 0.2× 49 0.6× 65 0.8× 13 0.2× 7 0.2× 60 246

Countries citing papers authored by Susan Ingle

Since Specialization
Citations

This map shows the geographic impact of Susan Ingle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Ingle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Ingle more than expected).

Fields of papers citing papers by Susan Ingle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Ingle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Ingle. The network helps show where Susan Ingle may publish in the future.

Co-authorship network of co-authors of Susan Ingle

This figure shows the co-authorship network connecting the top 25 collaborators of Susan Ingle. A scholar is included among the top collaborators of Susan Ingle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Ingle. Susan Ingle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Pacey, Simon, Nimish Shah, Barry R. Davies, et al.. (2018). A pharmacodynamic biomarker study of vistusertib (AZD2014), an mTORC1/2 inhibitor, given prior to radical prostatectomy (CANCAP02).. Journal of Clinical Oncology. 36(15_suppl). 5081–5081. 3 indexed citations
2.
Pacey, Simon, Nimish Shah, Ola Bratt, et al.. (2017). CANCAP02: A study into the pharmacodynamic biomarker effects of vistusertib (AZD2014), an mTORC1/2 inhibitor, given prior to radical prostatectomy (RP).. Journal of Clinical Oncology. 35(6_suppl). 97–97.
3.
Dorling, Leila, Siddhartha Kar, Kyriaki Michailidou, et al.. (2016). The Relationship between Common Genetic Markers of Breast Cancer Risk and Chemotherapy-Induced Toxicity: A Case-Control Study. PLoS ONE. 11(7). e0158984–e0158984. 8 indexed citations
5.
Abraham, Jean, Qi Guo, Leila Dorling, et al.. (2014). Replication of Genetic Polymorphisms Reported to Be Associated with Taxane-Related Sensory Neuropathy in Patients with Early Breast Cancer Treated with Paclitaxel. Clinical Cancer Research. 20(9). 2466–2475. 82 indexed citations
6.
Abraham, Jean, Mel Maranian, Inmaculada Spiteri, et al.. (2012). Saliva samples are a viable alternative to blood samples as a source of DNA for high throughput genotyping. BMC Medical Genomics. 5(1). 19–19. 120 indexed citations
7.
Abraham, Jean, Mel Maranian, Kristy Driver, et al.. (2010). CYP2D6 gene variants: association with breast cancer specific survival in a cohort of breast cancer patients from the United Kingdom treated with adjuvant tamoxifen. Breast Cancer Research. 12(4). R64–R64. 70 indexed citations
8.
Mackenzie, Iain, et al.. (2006). Hypoglycaemia? So what!. Intensive Care Medicine. 32(4). 620–621. 17 indexed citations
9.
Ingle, Susan, et al.. (1997). Read to Write : An Intergrated course for Nonnative Speakers of English. Medical Entomology and Zoology. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026